title: Slippery Slope of Triglycerides: They Are Associated With Risk, But in the Statin Era, Does Targeting Them Confer Benefit?
authors.affiliation: From the Division of Cardiology, David Geffen School of Medicine at University of California, Los Angeles. KWatson@mednet.ucla.edu.
authors.forename: Karol E
authors.initials: KE
authors.lastname: Watson
authors.affiliation: From the Division of Cardiology, David Geffen School of Medicine at University of California, Los Angeles.
authors.forename: Philipp
authors.initials: P
authors.lastname: Wiesner
mesh_terms: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D012306:Risk; D014280:Triglycerides
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014280:Triglycerides
keywords: Editorials; cholesterol; risk factor; survival rate; triglycerides